Rickettsia mooseri infection initiated by subcutaneous injection has been studied in BALB/c mice with the objective of developing a model for the study of immune mechanisms. Characterization of infection included the following: measurement of the replication, dissemination, and clearance of rickettsiae; measurement of correlates of the immune response, including humoral antibody, hypersensitivity to subcutaneously inoculated rickettsial antigen, and activation of nonspecific macrophage microbicidal capacity; and measurement of resistance to a second homologous challenge. Local infection at the site of subcutaneous injection progressed through day 5 and was controlled by day 7. Systemic infection as determined by the presence of rickettsiae in spleen was first detected on day 7 and progressed through day 14; however, rickettsiae persisted in this organ at reduced numbers through at least day 28. Control of the local infection at the site of subcutaneous injection occurred at about the time humoral antibodies and hypersensitivity reactions to subcutaneously injected rickettsial antigens became demonstrable and was paralleled by a capacity to resist homologous subcutaneous challenge at a site distant from that of the primary infection. Systemic infection progressed in spite of this acquired immune capacity and was controlled in the spleen in parallel with the development of enhanced macrophage microbicidal capacity in the liver. The results show that an acquired immunity is capable of restricting rickettsial growth at subcutaneous sites at a time when rickettsiae are increasing in titer in deep organs.
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Typhus fever (Rickettsia prowazekii infection) of humans usually develops 10 or more days after exposure to this obligate intracellular bacterial parasite and, in the absence of specific antibiotic therapy, may persist for about 2 to 3 weeks thereafter (19) . Cell-mediated immunity, measured as delayed hypersensitivity to R. prowazekii antigens, is regularly demonstrable in convalescence and may be present at the onset of disease, but is not demonstrable during the febrile disease (22) . On the other hand, antibodies are not detectable until near the end of week 1 of disease (16) , and the disseminated focal cutaneous vascular lesions begin to show the typical perivascular accumulation of dominantly mononuclear cells during this time (24) . Nevertheless, rickettsiae are demonstrable microscopically in swollen endothelial cells from about 3 to 5 days until 13 to 15 days after onset (24) and by louse feeding between about days 4 and 13 after onset (3, 24) . The reasons that the immune response fails to eliminate rickettsiae and limit disease more rapidly have not been explored.
In previous reports (6-9), we have used Rickettsia mooseri (Rickettsia typhi) infection of guinea pigs as a model of human typhus to address some of these questions. Guinea pigs rapidly (within 5 to 7 days) develop both anti-rickettsial antibodies and an antibody-independent cell-mediated capacity to eliminate rickettsiae from intradermal sites of infection. These capacities, however, do not prevent the later development of systemic infection and perivascular round cell infiltrates ("typhus nodules"). Our attempts to identify the mediators and effectors of the immune response and the mechanisms employed by the rickettsiae to avoid elimination were limited by the relative paucity of techniques for analyzing cellular defenses in guinea pigs. Because such techniques are more fully developed for mice, we * Corresponding author. Figure 1 shows that R. mooseri infection progressed and resolved rapidly (e.g., within 7 days) at the s.c. site of challenge, but splenic infection developed later and progressed more slowly, with maximum titers of rickettsiae at day 14, followed by a 10-fold reduction by day 21 and a persistence of this number of rickettsiae through at least day 28 (Fig. 1A) . By day 7, when the s.c. infection at the site of challenge had been controlled, mice possessed a capacity to resist s.c. challenges delivered at distant sites (Fig. 1B) ; mice also had serum antibody and evidence of immediate and delayed hypersensitivity to R. mooseri antigens (Fig. 1C) . All of these measures of immunity persisted through at least day 28, but their early development did not prevent the progress of splenic infection through day 14. Partial control of R. mooseri in the spleen was paralleled by a transient enhanced nonspecific macrophage microbicidal activity in the liver (Fig. 1D ).
DISCUSSION
This study shows that within 1 week of the s.c. introduction of a relatively small number of rickettsiae, BALB/c mice have an enhanced capacity to resist a homologous challenge delivered to a site distant from that employed for the primary infection. This observation, coupled with the evidence that infection at sites of primary infection is controlled by day 5 and the demonstration in vivo on day 7 of significant levels of hypersensitivity reactions to injections of killed R. mooseri and in vitro of anti-R. mooseri antibody, albeit in low titer, give credence to the proposition that these obligate intracellular bacterial parasites are strongly immunogenic and rapidly cause the generation of a protective systemically disseminated anti-R. mooseri immunological defense.
The kinetics of the development and deployment of this antibacterial resistance mechanism are not unusually rapid if viewed from the perspective of the dynamics of the immune response to some facultative intracellular bacteria. ample, the T cells which are the mediators of immunity to L. monocytogenes are generated in large numbers by days 4 to 6 of infection (12) , and available evidence supports the view that at least one of the rapidly produced mediators of immunity to R. mooseri is a T cell (Murphy, Ph.D. thesis, University of Maryland, Baltimore, 1976), possibly one which is phenotypically similar to that which mediates the anti-L. monocytogenes response. However, unlike the anti-L. monocytogenes response, which rapidly provides systemic resistance to this bacterium, the rapidly developing antirickettsial defense mechanism appears to be of limited efficacy in that, whereas clearance of rickettsiae from sites of primary inoculation or of distant s.c. second challenge correlates with this rapidly developing immunity, systemic infection, measured in this study as rickettsiae in the spleen, develops and progresses in the face of the early immune response. We emphasize this discordance of the development and expression of immunity between sites of infection because it is possible that such a segregation of acquisition and expression of immunity may play an important role in the pathogenesis of rickettsial infections of humans. Direct or inferential evidence supports the view that rickettsiae grow at a skin site of initiation of infection for a relatively short time, after which they are controlled or eliminated (6) . During the latter part of this initial sequence or relatively soon after its completion, systemic infection and overt disease occur. For example, it is clear that overt clinical typhus fevers develop and persist in the face of building or mature immune responses (6, 19, (22) (23) (24) . Although the precise dynamics of the infectious processes and the immune responses may differ for each organism, it may be that this phenomenon holds in principle for infections caused by other members of the genus Rickettsia. These observations raise questions of the capacities and limitations of immunological defenses to rickettsial infections, and, because the primary pathological lesion of these infections is a round cell perivascular infiltrate (typhus nodule), some have questioned whether there is an immunological component to this pathology (23) . Resolution of these points is of central importance to the design of appropriate immunoprophylactic procedures and of therapy regimens. Studies of the relationship between course of R. mooseri infection and immune response in guinea pigs (6) (7) (8) (9) and rats (S. Arango-Jaramillo, Ph.D. thesis, University of Maryland, Baltimore, 1979) provide further evidence of the similarities among mammals of the relationship between course of infection and immune response as cited above. 24 -h hypersensitivity responses failed to established a direct relationship between any of these correlates of immunity and the number of rickettsiae. Therefore, the studies were extended to include the measurement of nonspecific macrophage microbicidal activity. A direct relationship among appearance in liver of macrophages with enhanced microbicidal capacities, the arrest of the progression of infection in spleen, and a subsequent reduction in rickettsial numbers was demonstrated. However, after infection was controlled, a reduced number of rickettsiae persisted in the spleen in the absence of activated macrophages. Whether the observed relationshp between control of splenic infection and the appearance of activated macrophages is causal or coincidental remains to be determined.
Naturally acquired rickettsial infections often result from contamination of skin of a susceptible host with arthropodborne rickettsiae. These rickettsiae appear to replicate locally before systemic dissemination and appear to show, in every instance where detailed analysis has been conducted, that the complex interrelationships with the immune response are as summarized above. We have attempted to mimic this natural sequence in a manner sensitive to laboratory analysis by introducing in this and previous (6-9) studies relatively small numbers of rickettsiae by peripheral routes. This results in a sequential evolution of infection and immune response (Fig. 1) 
